ID: ALA2338803

Max Phase: Preclinical

Molecular Formula: C12H10F2N2O2

Molecular Weight: 252.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=c1[nH]nc(CCc2cc(F)cc(F)c2)cc1O

Standard InChI:  InChI=1S/C12H10F2N2O2/c13-8-3-7(4-9(14)5-8)1-2-10-6-11(17)12(18)16-15-10/h3-6H,1-2H2,(H,15,17)(H,16,18)

Standard InChI Key:  BLEWCUQOJLGDAH-UHFFFAOYSA-N

Associated Targets(Human)

D-amino-acid oxidase 802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsome 8277 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 6361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Brain 4203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

D-amino-acid oxidase 58 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

D-amino-acid oxidase 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver microsome 4459 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 252.22Molecular Weight (Monoisotopic): 252.0710AlogP: 1.54#Rotatable Bonds: 3
Polar Surface Area: 65.98Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.08CX Basic pKa: CX LogP: 2.02CX LogD: 1.53
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -0.86

References

1. Hondo T, Warizaya M, Niimi T, Namatame I, Yamaguchi T, Nakanishi K, Hamajima T, Harada K, Sakashita H, Matsumoto Y, Orita M, Takeuchi M..  (2013)  4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.,  56  (9): [PMID:23566269] [10.1021/jm400095b]
2. Zimmermann SC, Rais R, Alt J, Burzynski C, Slusher BS, Tsukamoto T..  (2014)  Structure-Metabolism Relationships in the Glucuronidation of d-Amino Acid Oxidase Inhibitors.,  (11): [PMID:25408840] [10.1021/ml500335z]
3. Hin N, Duvall B, Ferraris D, Alt J, Thomas AG, Rais R, Rojas C, Wu Y, Wozniak KM, Slusher BS, Tsukamoto T..  (2015)  6-Hydroxy-1,2,4-triazine-3,5(2H,4H)-dione Derivatives as Novel D-Amino Acid Oxidase Inhibitors.,  58  (18): [PMID:26309148] [10.1021/acs.jmedchem.5b00482]
4. Hin N, Duvall B, Berry JF, Ferraris DV, Rais R, Alt J, Rojas C, Slusher BS, Tsukamoto T..  (2016)  D-Amino acid oxidase inhibitors based on the 5-hydroxy-1,2,4-triazin-6(1H)-one scaffold.,  26  (8): [PMID:26965861] [10.1016/j.bmcl.2016.02.068]
5.  (2015)  Dihydroxy aromatic heterocyclic compound, 
6.  (2016)  Pyridazinone compounds and their use as DAAO inhibitors,